Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Coens C"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 55
Tytuł:
Quality of life of long-term childhood acute lymphoblastic leukemia survivors: Comparison with healthy controls.
Autorzy:
Chantziara S; School of Health Sciences, University of Southampton, Southampton, UK.
Musoro J; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Rowsell AC; School of Health Sciences, University of Southampton, Southampton, UK.
Sleurs C; Department of Oncology, KU Leuven, Leuven, Belgium.; Department of Cognitive Neuropsychology, Tilburg University, Tilburg, The Netherlands.
Coens C; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Pe M; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Suciu S; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Kicinski M; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Missotten P; Unité de Psychologie de la Sénescence, Université de Liège, Liège, Belgium.
Vandecruys E; Department of Pediatric Hematology-Oncology, Ghent University Hospital, Ghent, Belgium.
Uyttebroeck A; Department of Pediatric Hemato-Oncology, University Hospital Leuven, Leuven, Belgium.
Dresse MF; Division of Haematology-Oncology, Department of Paediatrics, University Hospital Liège and University of Liège, Liège, Belgium.
Pluchart C; Department of Pediatric Haematology and Oncology, CHU Reims, Reims, France.
Ferster A; Department of Hemato-Oncology, HUDERF (ULB), Brussels, Belgium.
Freycon C; Department of Pediatric Hematology-Oncology, CHU Grenoble, Grenoble, France.
Bosch JVWT; VUB, Brussels, Belgium.
Rohrlich P; Pediatric Oncology, CHU Nice, Nice, France.
Benoit Y; Department of Pediatric Hematology-Oncology, Ghent University Hospital, Ghent, Belgium.
Darlington AS; School of Health Sciences, University of Southampton, Southampton, UK.
Piette C; Division of Haematology-Oncology, Department of Paediatrics, University Hospital Liège and University of Liège, Liège, Belgium.
Pokaż więcej
Corporate Authors:
European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life (QLG) and Children's Leukemia Group (CLG)
Źródło:
Psycho-oncology [Psychooncology] 2022 Dec; Vol. 31 (12), pp. 2159-2168. Date of Electronic Publication: 2022 Nov 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Quality of Life*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/psychology
Child ; Humans ; Adult ; Survivors/psychology ; Mental Health ; Self Concept
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials.
Autorzy:
Gamper EM; Innsbruck Institute of Patient-centered Outcome Research (IIPCOR), Innsbruck, Austria. .
Musoro JZ; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Coens C; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Stelmes JJ; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
Falato C; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Groenvold M; Department of Public Health, University of Copenhagen, and Bispebjerg Hospital, Copenhagen, Denmark.
Velikova G; Leeds Institute of Cancer and Pathology, University of Leeds, St James's Hospital, Leeds, UK.
Cocks K; Adelphi Value, Bollington, Cheshire, UK.
Flechtner HH; Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany.
King MT; University of Sydney, Faculty of Science, School of Psychology, Sydney, NSW, Australia.
Bottomley A; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Pokaż więcej
Corporate Authors:
EORTC Genito-Urinary Tract Cancer Group and Quality of Life Groups
Źródło:
BMC cancer [BMC Cancer] 2021 Oct 07; Vol. 21 (1), pp. 1083. Date of Electronic Publication: 2021 Oct 07.
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Deterioration*
Diarrhea*
Health Surveys*
Prostatic Neoplasms*
Quality of Life*
Severity of Illness Index*
Aged ; Cancer Pain ; Clinical Trials, Phase III as Topic/statistics & numerical data ; Denture Liners ; Europe ; Fatigue ; Humans ; Male ; Middle Aged ; Patient Reported Outcome Measures ; Physical Functional Performance ; Social Interaction ; Time Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors.
Autorzy:
Vachon H; EORTC, Brussels, Belgium.
Mierzynska J; EORTC, Brussels, Belgium.
Taye M; EORTC, Brussels, Belgium.
Pe M; EORTC, Brussels, Belgium.
Coens C; EORTC, Brussels, Belgium.
Martinelli F; EORTC, Brussels, Belgium.
Fortpied C; EORTC, Brussels, Belgium.
Flechtner HH; University of Magdeburg, Magdeburg, Germany.
Vestmoe Maraldo M; Rigshospitalet, Copenhagen, Denmark.
Hutchings M; Rigshospitalet, Copenhagen, Denmark.
Meijnders P; Iridium Kankernetwerk, Wilrijk, Belgium.; University of Antwerp, Antwerp, Belgium.
Aleman B; Netherlands Cancer Institute, Amsterdam, The Netherlands.
Lugtenburg P; Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Spina M; Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Italy.
André M; Department of Haematology, CHU UCL Namur, Yvoir, Belgium.
Hertzberg M; Prince of Wales Hospital, Randwick, Australia.
Briones J; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Bottomley A; EORTC, Brussels, Belgium.
Pokaż więcej
Corporate Authors:
EORTC Quality of Life Group, Lymphoma Group
Źródło:
European journal of haematology [Eur J Haematol] 2021 May; Vol. 106 (5), pp. 697-707. Date of Electronic Publication: 2021 Feb 28.
Typ publikacji:
Journal Article
MeSH Terms:
Cancer Survivors*/statistics & numerical data
Quality of Life*
Hodgkin Disease/*epidemiology
Age Factors ; Databases, Factual ; Europe/epidemiology ; Female ; Hodgkin Disease/pathology ; Hodgkin Disease/therapy ; Humans ; Male ; Public Health Surveillance ; Sex Factors ; Surveys and Questionnaires
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of neurocognitive deficits on patient-proxy agreement regarding health-related quality of life in low-grade glioma patients.
Autorzy:
Ediebah DE; Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Reijneveld JC; Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands.
Taphoorn MJ; Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands.; Department of Neurology, Medical Center Haaglanden, The Hague, The Netherlands.
Coens C; Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Zikos E; Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Aaronson NK; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Heimans JJ; Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands.
Bottomley A; Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Klein M; Department of Medical Psychology - B7D349, VU University Medical Center, Van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands. .
Pokaż więcej
Corporate Authors:
EORTC Quality of Life Department and Patient Reported Outcome and Behavioral Evidence (PROBE)
Źródło:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2017 Apr; Vol. 26 (4), pp. 869-880. Date of Electronic Publication: 2016 Oct 15.
Typ publikacji:
Journal Article
MeSH Terms:
Quality of Life*
Brain Neoplasms/*complications
Cognitive Dysfunction/*psychology
Glioma/*complications
Adult ; Brain Neoplasms/pathology ; Cognitive Dysfunction/complications ; Cross-Sectional Studies ; Data Interpretation, Statistical ; Female ; Glioma/pathology ; Humans ; Male ; Neoplasm Grading ; Netherlands ; Proxy ; Self Report
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Joint modeling of longitudinal health-related quality of life data and survival.
Autorzy:
Ediebah DE; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium, .
Galindo-Garre F
Uitdehaag BM
Ringash J
Reijneveld JC
Dirven L
Zikos E
Coens C
van den Bent MJ
Bottomley A
Taphoorn MJ
Pokaż więcej
Źródło:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2015 Apr; Vol. 24 (4), pp. 795-804. Date of Electronic Publication: 2014 Oct 14.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Outcome Assessment, Health Care*
Quality of Life*
Brain Neoplasms/*mortality
Oligodendroglioma/*mortality
Adolescent ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Brain Neoplasms/drug therapy ; Brain Neoplasms/radiotherapy ; Female ; Humans ; Lomustine/therapeutic use ; Male ; Middle Aged ; Models, Statistical ; Oligodendroglioma/drug therapy ; Oligodendroglioma/radiotherapy ; Procarbazine/therapeutic use ; Surveys and Questionnaires ; Time ; Treatment Outcome ; Vincristine/therapeutic use ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Longitudinal quality of life data: a comparison of continuous and ordinal approaches.
Autorzy:
Donneau AF; Medical Informatics and Biostatistics, University of Liège, Liège, Belgium, .
Mauer M
Coens C
Bottomley A
Albert A
Pokaż więcej
Źródło:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2014 Dec; Vol. 23 (10), pp. 2873-81. Date of Electronic Publication: 2014 Jun 06.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Health Status*
Quality of Life*
Brain Neoplasms/*psychology
Aged ; Antineoplastic Agents/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols ; Appetite ; Brain Neoplasms/drug therapy ; Brain Neoplasms/radiotherapy ; Combined Modality Therapy ; Dacarbazine/analogs & derivatives ; Dacarbazine/therapeutic use ; Female ; Humans ; Longitudinal Studies ; Middle Aged ; Procarbazine/therapeutic use ; Randomized Controlled Trials as Topic ; Sleep Initiation and Maintenance Disorders/epidemiology ; Sleep Stages ; Surveys and Questionnaires ; Temozolomide ; Vincristine/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial.
Autorzy:
Ediebah DE; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Avenue Mounier, 83 b11, 1200 Brussels, Belgium.
Coens C; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Avenue Mounier, 83 b11, 1200 Brussels, Belgium.
Zikos E; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Avenue Mounier, 83 b11, 1200 Brussels, Belgium.
Quinten C; 1] Quality of Life Department, European Organisation for Research and Treatment of Cancer, Avenue Mounier, 83 b11, 1200 Brussels, Belgium [2] Department of Biostatistics, European Centre for Disease Prevention and Control, Surveillance and Response Support Unit, Tomtebodavägen 11a, 171 83 Stockholm, Sweden.
Ringash J; Department of Radiation Oncology, The Princess Margaret Hospital and the University of Toronto, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9.
King MT; Department of Psychology, Psycho-oncology Co-operative Research Group (PoCoG), The University of Sydney, Sydney, New South Wales NSW 2006, Australia.
Schmucker von Koch J; Department of Ethics, University of Regensburg, Medical Ethics, Universitaetsstrasse 31, D-93040 Regensburg, Germany.
Gotay C; School of Population and Public Health, University of British Columbia, Room 162-2206 East Mall, Vancouver, British Columbia, Canada BC V6T 1Z3.
Greimel E; Department of Obstetrics and Gynecology, Medical University Graz, Auenbruggerplatz 14, AT 8036 Graz, Austria.
Flechtner H; Department of Child and Adolescent Psychiatry, University Magdeburg, Leipziger Str 44, 39120 Magdeburg, Germany.
Weis J; Psychosocial Department, Tumor Biology Center at the University of Freiburg, Breisacher Str. 117, 79106 Freiburg, Germany.
Reeve BB; Department of Health Policy and Management, University of North Carolina at Chapel Hill, 1101-D McGavran-Greenberg Building Chapel Hill, Chapel Hill, NC 27599, USA.
Smit EF; Department of Pulmonology, VU University Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands.
Taphoorn MJ; Department of Neurology, VU University Medical Center/Medical Center Haaglanden 2501 CK, The Hague, The Netherlands.
Bottomley A; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Avenue Mounier, 83 b11, 1200 Brussels, Belgium.
Pokaż więcej
Źródło:
British journal of cancer [Br J Cancer] 2014 May 13; Vol. 110 (10), pp. 2427-33. Date of Electronic Publication: 2014 Apr 17.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Quality of Life*
Carcinoma, Non-Small-Cell Lung/*mortality
Lung Neoplasms/*mortality
Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/psychology ; Cisplatin/administration & dosage ; Clinical Trials, Phase III as Topic/statistics & numerical data ; Deglutition Disorders/epidemiology ; Deglutition Disorders/etiology ; Deoxycytidine/administration & dosage ; Deoxycytidine/analogs & derivatives ; Humans ; Interpersonal Relations ; Lung Neoplasms/drug therapy ; Lung Neoplasms/psychology ; Multicenter Studies as Topic/statistics & numerical data ; Nausea/epidemiology ; Nausea/etiology ; Paclitaxel/administration & dosage ; Pain/epidemiology ; Pain/etiology ; Palliative Care ; Prognosis ; Proportional Hazards Models ; Randomized Controlled Trials as Topic/statistics & numerical data ; Risk ; Severity of Illness Index ; Surveys and Questionnaires ; Survival Analysis ; Gemcitabine
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323).
Autorzy:
van Herpen CM; Department of Medical Oncology, Radboud University Nijmegen Medical Centre, 452, PO Box 9101, 6500 HB Nijmegen, The Netherlands. C. />Mauer ME
Mesia R
Degardin M
Jelic S
Coens C
Betka J
Bernier J
Remenar E
Stewart JS
Preiss JH
van den Weyngaert D
Bottomley A
Vermorken JB
Pokaż więcej
Corporate Authors:
EORTC Head and Neck Group
Źródło:
British journal of cancer [Br J Cancer] 2010 Oct 12; Vol. 103 (8), pp. 1173-81. Date of Electronic Publication: 2010 Sep 14.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Quality of Life*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Carcinoma, Squamous Cell/*drug therapy
Head and Neck Neoplasms/*drug therapy
Taxoids/*administration & dosage
Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/pathology ; Carcinoma, Squamous Cell/physiopathology ; Cisplatin/administration & dosage ; Cisplatin/adverse effects ; Cisplatin/therapeutic use ; Disease Progression ; Docetaxel ; Fluorouracil/administration & dosage ; Fluorouracil/adverse effects ; Fluorouracil/therapeutic use ; Head and Neck Neoplasms/mortality ; Head and Neck Neoplasms/pathology ; Head and Neck Neoplasms/physiopathology ; Health Status ; Humans ; Taxoids/adverse effects ; Taxoids/therapeutic use ; Time Factors ; Treatment Outcome
SCR Protocol:
TPF protocol
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Statistical methodology is crucial in prognostic factor analysis of health-related quality of life.
Autorzy:
Mauer ME; Quality of Life Department, European Organization for Research and Treatment of Cancer, Brussels, Belgium. />Bottomley A
Coens C
Pokaż więcej
Źródło:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2008 Sep; Vol. 17 (7), pp. 1043-4; discussion 1045-6. Date of Electronic Publication: 2008 May 24.
Typ publikacji:
Comment; Journal Article
MeSH Terms:
Factor Analysis, Statistical*
Quality of Life*
Sickness Impact Profile*
Humans ; Neoplasms/mortality ; Neoplasms/psychology ; Prognosis ; Survival Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study.
Autorzy:
Mauer M; European Organisation for Research and Treatment of Cancer, Quality of Life Unit, Data Center, Avenue Mounier 83/11, 1200 Brussels, Belgium. />Stupp R
Taphoorn MJ
Coens C
Osoba D
Marosi C
Wong R
de Witte O
Cairncross JG
Efficace F
Mirimanoff RO
Forsyth P
van den Bent MJ
Weller M
Bottomley A
Pokaż więcej
Źródło:
British journal of cancer [Br J Cancer] 2007 Aug 06; Vol. 97 (3), pp. 302-7. Date of Electronic Publication: 2007 Jul 03.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Quality of Life*
Survival Analysis*
Brain Neoplasms/*physiopathology
Glioblastoma/*physiopathology
Female ; Humans ; Male ; Middle Aged ; Prognosis ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Minimally important differences for interpreting the EORTC QLQ‐C30 in patients with advanced colorectal cancer treated with chemotherapy.
Autorzy:
Musoro, J. Z.
Sodergren, S. C.
Coens, C.
Pochesci, A.
Terada, M.
King, M. T.
Sprangers, M. A. G.
Groenvold, M.
Cocks, K.
Velikova, G.
Flechtner, H.‐H.
Bottomley, A.
Pokaż więcej
Temat:
CANCER chemotherapy
COLORECTAL cancer
QUALITY of life
ABSOLUTE value
EXPERIMENTAL design
Źródło:
Colorectal Disease; Dec2020, Vol. 22 Issue 12, p2278-2287, 10p
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 55

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies